Company Analysis

Senti Biosciences Holdings, Inc. (SNTI)

Nasdaq: SNTI · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2021
Grade2.6
◀ Past 1.2● Present 2.1▶ Future 3.9
2 est.

The company now

Senti Biosciences Holdings, Inc. is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in South San Francisco, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $22 thousand and a loss of $61 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.

SI Assistanton SNTI · research, not advice